-74%

est. 2Y upside i

HealthcareSeries A

Stage: growth. Country: Germany

Rank

#2253

Sector

Healthcare Technology

Est. Liquidity

~4Y

Data Quality

Data: Low

Entyre operates in a high-growth healthcare technology sector with a differentiated AI-driven platform, offering moderate upside potential if it can successfully navigate significant market and regulatory challenges.

Last updated: February 23, 2026

Bull (15%)+300%

Entyre achieves significant market penetration, expands successfully into new regions, and secures substantial follow-on funding, leading to a successful acquisition or IPO.

Base (50%)+50%

Entyre continues steady growth, expands its platform features, and maintains its competitive position, leading to a modest valuation increase or a strategic acquisition.

Bear (35%)-80%

Entyre faces intense competition, struggles with regulatory hurdles or market adoption, or fails to secure necessary follow-on funding, resulting in a significantly reduced valuation or acquisition at a low price.

Est. time to liquidity~4.0 years

Preference Stack Risk

low

Investors hold $2M in liquidation preferences, which is 4.44% of the estimated current valuation of $45M.

Dilution Risk

high

As a Series A company, Entyre will likely require several more funding rounds, leading to significant future dilution for common shareholders.

Secondary Liquidity

none

There is no active secondary market or tender offers for Entyre's shares at this early stage.

Community

Valuation Sentiment

Our model estimates -74% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.